JP2008524235A5 - - Google Patents

Download PDF

Info

Publication number
JP2008524235A5
JP2008524235A5 JP2007546882A JP2007546882A JP2008524235A5 JP 2008524235 A5 JP2008524235 A5 JP 2008524235A5 JP 2007546882 A JP2007546882 A JP 2007546882A JP 2007546882 A JP2007546882 A JP 2007546882A JP 2008524235 A5 JP2008524235 A5 JP 2008524235A5
Authority
JP
Japan
Prior art keywords
composition
implant
polar aprotic
optionally
octreotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007546882A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008524235A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/045346 external-priority patent/WO2006065951A2/en
Publication of JP2008524235A publication Critical patent/JP2008524235A/ja
Publication of JP2008524235A5 publication Critical patent/JP2008524235A5/ja
Pending legal-status Critical Current

Links

JP2007546882A 2004-12-15 2005-12-15 オクトレオチド化合物の徐放性送達処方物 Pending JP2008524235A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63627304P 2004-12-15 2004-12-15
PCT/US2005/045346 WO2006065951A2 (en) 2004-12-15 2005-12-15 Sustained delivery formulations of octreotide compounds

Publications (2)

Publication Number Publication Date
JP2008524235A JP2008524235A (ja) 2008-07-10
JP2008524235A5 true JP2008524235A5 (enExample) 2009-01-29

Family

ID=36588524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007546882A Pending JP2008524235A (ja) 2004-12-15 2005-12-15 オクトレオチド化合物の徐放性送達処方物

Country Status (6)

Country Link
US (1) US20090092650A1 (enExample)
EP (1) EP1838285A2 (enExample)
JP (1) JP2008524235A (enExample)
AU (1) AU2005316545A1 (enExample)
CA (1) CA2590696A1 (enExample)
WO (1) WO2006065951A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
EP2079767B1 (en) * 2006-10-11 2014-08-27 Tolmar Therapeutics, Inc. Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
US8877225B2 (en) 2008-06-03 2014-11-04 Tolmar Therapeutics, Inc. Controlled release copolymer formulation with improved release kinetics
AR074603A1 (es) * 2008-12-15 2011-01-26 Novartis Ag Formulacion de deposito de octreotida con niveles de exposicion constantemente altos.uso. metodo. kit
US8815971B2 (en) 2008-12-22 2014-08-26 ATRP Solutions, Inc. Control over controlled radical polymerization processes
US8822610B2 (en) 2008-12-22 2014-09-02 ATRP Solutions, Inc. Control over controlled radical polymerization processes
US8173750B2 (en) 2009-04-23 2012-05-08 ATRP Solutions, Inc. Star macromolecules for personal and home care
US9783628B2 (en) 2009-04-23 2017-10-10 ATRP Solutions, Inc. Dual-mechanism thickening agents for hydraulic fracturing fluids
WO2010123574A1 (en) 2009-04-23 2010-10-28 Atrp Solutions Inc Star macromolecules for personal and home care
US9155745B2 (en) * 2009-06-16 2015-10-13 Universite De Geneve Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs
WO2011015958A2 (en) 2009-08-06 2011-02-10 Koninklijke Philips Electronics N.V. Oncology therapies employing radioactive seeds
WO2011087496A1 (en) * 2010-01-13 2011-07-21 Oakwood Laboratories LLC Microspheres for the sustained release of octreotide without an initial time lag
US20110229457A1 (en) * 2010-03-12 2011-09-22 Surmodics, Inc. Injectable drug delivery system
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9587064B2 (en) 2010-12-08 2017-03-07 ATRP Solutions, Inc. Salt-tolerant star macromolecules
EP2890760A4 (en) 2012-08-30 2016-10-12 Atrp Solutions Inc DOUBLE MECHANISM THICKENERS FOR HYDRAULIC FRACKING FLUIDS
EP2951220B1 (en) 2013-02-04 2020-11-25 Pilot Polymer Technologies, Inc. Salt-tolerant star macromolecules
EP2823808A1 (en) * 2013-07-09 2015-01-14 Ipsen Pharma S.A.S. Pharmaceutical composition for a sustained release of lanreotide
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
MX385886B (es) 2014-07-03 2025-03-18 Pilot Polymer Tech Inc Macromoleculas estrellas compatibles con tensoactivos.
US20160128997A1 (en) 2014-11-07 2016-05-12 Indivior Uk Limited Sustained-release buprenorphine formulations
US10786515B2 (en) 2015-08-03 2020-09-29 Tolmar International Limited Liquid polymer delivery system for extended administration of drugs
WO2017083800A1 (en) * 2015-11-13 2017-05-18 Ohr Pharmaceutical, Inc. Occult cnv size as a predictor for treatment with squalamine
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
CA3087238A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
CN111989068B (zh) 2018-05-24 2024-10-25 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
WO2020087203A1 (en) * 2018-10-29 2020-05-07 Pujing Chemical Industry Co., Ltd Heat and aging resistant polyglycolide copolymer and composition thereof
CN112469762A (zh) * 2018-10-29 2021-03-09 上海浦景化工技术股份有限公司 聚乙交酯共聚物及其制备方法
CN111214643A (zh) * 2020-03-11 2020-06-02 苏州善湾生物医药科技有限公司 一种基于皮下凝胶缓释的奥曲肽组合物、制备方法及应用
EP4329734A4 (en) 2021-04-26 2025-04-02 Celanese EVA Performance Polymers LLC Implantable device for the delayed release of a macromolecular drug compound
CN113318218A (zh) * 2021-07-20 2021-08-31 国药一心制药有限公司 一种醋酸奥曲肽注射液及其制备工艺
CN120131956A (zh) * 2023-12-11 2025-06-13 中山大学中山眼科中心 生长激素抑制剂的用途、和含有生长激素抑制剂的药物组合物、制剂、及其装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
AU2002232824A1 (en) * 2000-12-21 2002-07-01 Inhale Therapeutic Systems, Inc. Induced phase transition method for the production of microparticles containing hydrophobic active agents
WO2002058671A1 (en) * 2001-01-26 2002-08-01 Debio Recherche Pharmaceutique S.A. Burst free pharmaceutical microparticules
AU2003287472A1 (en) * 2002-11-05 2004-06-03 Wellstat Biologics Corporation Treating carcinoid neoplasms with therapeuthic viruses
US7368126B2 (en) * 2002-11-06 2008-05-06 Guohua Chen Controlled release depot formulations
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
US7803781B2 (en) * 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
WO2004081196A2 (en) * 2003-03-11 2004-09-23 Qlt Usa Inc. Formulations for cell- schedule dependent anticancer agents
WO2006099288A2 (en) * 2005-03-11 2006-09-21 Indevus Pharmaceuticals, Inc. Controlled release formulations of octreotide

Similar Documents

Publication Publication Date Title
US20220354956A1 (en) Biodegradable drug delivery for hydrophobic compositions
CA2822854C (en) Biodegradable drug delivery compositions
ES2240236T3 (es) Composicion de polimero biodegradable.
CN101801415B (zh) 利培酮化合物的持续递送制剂
JP6061823B2 (ja) 改良された効力を備えた、ロイプロリドのポリマー送達処方物
JP4686653B2 (ja) 低い初期薬物噴出性を有する制御放出性液状デリバリー組成物
JP2004510807A5 (enExample)
US20090181068A1 (en) Low Viscosity Liquid Polymeric Delivery System
JPH05286850A (ja) 放出を制御されたインプラントに使用する液状混合物、インプラントに好適なポリマーシステム及びそのポリマーシステムを用いた治療方法
JP2010531807A5 (enExample)
RS56820B1 (sr) Injektabilna tečna kompozicija koja sadrži buprenorfin
JP2002537221A (ja) 成形可能な固体のデリバリーシステム
CN102112107A (zh) 具有改进的释放动力学特征的控制释放共聚物制剂
KR20200072322A (ko) 온도감응형 하이드로겔을 이용한 서방성 약물전달체 제조방법
ES2370377T3 (es) Sistema de administración de un líquido polimérico de baja viscosidad.
Singh et al. In Situ Forming Phase–inversion injectable Hydrogels for Controlled Drug Release